First Horizon Corporation’s Ligand Pharmaceuticals LGND Stock Holding History

First Horizon Corporation's LGND Position: Q1 2026 in Review

First Horizon Corporation reduced its Ligand Pharmaceuticals (LGND) stake by 2.1% in Q1 2026, selling an estimated $2.37K and leaving 562 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

First Horizon Corporation first reported a position in LGND in Q3 2020 and has held it in 4 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

• First Horizon Corporation held 562 shares of Ligand Pharmaceuticals worth $112K as of Q1 2026.
• First Horizon Corporation sold 12 Ligand Pharmaceuticals shares in Q1 2026, an estimated $2.37K.
• Ligand Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q1 2026, its #480 holding.
• First Horizon Corporation first reported a position in Ligand Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
• 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on First Horizon Corporation's 13F filing for Q1 2026, filed 30 Apr 2026.